These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3782959)

  • 21. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
    Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M
    Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptors in human uterine adenocarcinoma: correlation with tissue differentiation, vaginal karyopycnotic index, and effect of progestogen or anti-estrogen treatment.
    Billiet G; De Hertogh R; Bonte J; Ide P; Vlaemynck G
    Gynecol Oncol; 1982 Aug; 14(1):33-9. PubMed ID: 6212297
    [No Abstract]   [Full Text] [Related]  

  • 23. Human endometrial cancer cell cultures for hormonal studies.
    Satyaswaroop PG; Fleming H; Bressler RS; Gurpide E
    Cancer Res; 1978 Nov; 38(11 Pt 2):4367-75. PubMed ID: 698977
    [No Abstract]   [Full Text] [Related]  

  • 24. [Estrogen and progesterone receptors in endometrial carcinoma following endometrial radiation therapy].
    Thurzó L; Falkay G; Sas M
    Orv Hetil; 1985 Jan; 126(3):137-9. PubMed ID: 4038551
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of protein expression in endometrial adenocarcinoma cells by in vitro exposure to estradiol and progesterone.
    O'Brien TJ; Hernandez W; Jernstrom PJ; Seymour DB; Morrow CP; Sykes JA
    Am J Obstet Gynecol; 1981 Jan; 139(1):67-72. PubMed ID: 7457524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment and characterization of two histologically differentiated human uterine endometrial carcinoma cell lines from the same patient--a correlation between grade of morphological differentiation and HLA antigens].
    Tanaka K; Higuchi M; Hando T; Yoshiya N; Adachi S; Tanaka K; Honma S; Motani N; Kanazawa K; Honda T
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):1975-81. PubMed ID: 3794448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of estradiol and prolactin on growth of rat mammary adenocarcinoma cells in monolayer cultures.
    Chan PC; Tsuang J; Head J; Cohen LA; Weisburger JH
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):362-5. PubMed ID: 943106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.
    Budwit-Novotny DA; McCarty KS; Cox EB; Soper JT; Mutch DG; Creasman WT; Flowers JL; McCarty KS
    Cancer Res; 1986 Oct; 46(10):5419-25. PubMed ID: 3756890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The level of steroid hormone receptors in endometrial cancer].
    Bieglmayer C; Spona J; Ulm R; Husslein P
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6211045
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth potential of human uterine leiomyomas: some in vitro observations and their implications.
    Cramer SF; Robertson AL; Ziats NP; Pearson OH
    Obstet Gynecol; 1985 Jul; 66(1):36-41. PubMed ID: 3892387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
    Zaino RJ; Satyaswaroop PG; Mortel R
    Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endocrine therapy of lung cancer].
    Sagara N; Hara S; Nakano K; Haeno Y; Mori N; Aisawa M; Kurooka K; Matuda T; Wada T; Shindou K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):859-61. PubMed ID: 2712581
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of estrogen receptor status on survival in patients with endometrial cancer.
    Martin JD; Hähnel R; McCartney AJ; Woodings TL
    Am J Obstet Gynecol; 1983 Oct; 147(3):322-4. PubMed ID: 6624797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological characteristics of cultured endometrial adenocarcinoma cells and changes in their characteristics following serial passage.
    Ishiwata I; Ishiwata C; Nozawa S; Ishikawa H
    Asia Oceania J Obstet Gynaecol; 1986 Sep; 12(3):433-42. PubMed ID: 3778323
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of endometrial carcinoma cell cultures by a synthetic androgen.
    Centola GM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6264-7. PubMed ID: 3877566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
    Thurzó L; Sas M; Falkay G
    Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
    [No Abstract]   [Full Text] [Related]  

  • 40. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
    Horvath G; Fernö M; Cameron R; Ranstam J
    In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.